A PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT

被引：0
|
作者：
Fogh, Shannon E.
Machtay, Mitchell
Werner-Wasik, Maria
Curran, Walter
Bonanni, Roseann
Axelrod, Rita
Andrews, David W.
Dicker, Adam P.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 663
页数：1
相关论文
共 50 条
  • [21] First-in-human phase I trial of a novel epothilone, KOS-1584.
    Villalona-Calero, M.
    Goel, S.
    Schaaf, L.
    McCracken, B.
    Desai, K.
    Cropp, G.
    Zhou, Y.
    Johnson, R. G.
    Hannah, A. L.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 79S - 79S
  • [22] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer
    Melichar, Bohuslav
    Casado, Esther
    Tabemero, Josep
    Hosseinzadeh, Sharareh
    Hamm, John
    Wadler, Scott
    Bridgewater, John
    Holland, Jaymes
    Sklenar, Ivo
    Johri, Anandhi
    ANNALS OF ONCOLOGY, 2004, 15 : 85 - 85
  • [23] Phase I trial of concurrent chemoradiotherapy using doxifluridine and paclitaxel in advanced breast cancer
    Hirowatari, H.
    Karasawa, K.
    Ito, K.
    Takada, F.
    Izawa, H.
    Furuya, T.
    Kurokawa, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S238 - S238
  • [24] A phase I clinical trial of BMS-247550 (NSC 710428), an epothilone B analog, in patients with refractory neoplasms.
    Fojo, AT
    Kotz, H
    Abraham, J
    Agrawal, M
    Bates, SE
    Balis, F
    Widemann, B
    Bakke, S
    Edgerly, M
    Rutt, A
    Damle, B
    Sonnichsen, D
    Lebwohl, D
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3809S - 3809S
  • [25] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Interaction of Epothilone B (Patupilone) with Microtubules as Detected by Two-Dimensional Solid-State NMR Spectroscopy
    Kumar, Ashutosh
    Heise, Henrike
    Blommers, Marcel J. J.
    Krastel, Philipp
    Schmitt, Esther
    Petersen, Frank
    Jeganathan, Siva
    Mandelkow, Eva-Maria
    Carlomagno, Teresa
    Griesinger, Christian
    Baldus, Marc
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (41) : 7504 - 7507
  • [27] A phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days
    Zhuang, SH
    Agrawal, M
    Edgerly, M
    Bakke, S
    Kotz, H
    Thambi, P
    Rutt, A
    Balis, FM
    Bates, S
    Fojo, T
    CANCER, 2005, 103 (09) : 1932 - 1938
  • [28] Phase II trial of patupilone in patients with breast cancer brain metastases
    Peereboom, David
    Brewer, Cathy
    Seidman, Andrew
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 523
  • [29] Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days
    Abraham, J
    Agrawal, M
    Bakke, S
    Rutt, A
    Edgerly, M
    Balis, FM
    Widemann, B
    Davis, L
    Damle, B
    Sonnichsen, D
    Lebwohl, D
    Bates, S
    Kotz, H
    Fojo, T
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) : 1866 - 1873
  • [30] Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: An in-vitro study
    Choi, Eve P.
    Yau, Daisy M. S.
    Wong, Cesar S. C.
    Mok, Tony S. K.
    CANCER RESEARCH, 2006, 66 (08)
12345